BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9503680)

  • 1. [A novel immune system].
    Taniguchi M; Sato H; Cui J; Kawano T
    Arerugi; 1997 Dec; 46(12):1216-23. PubMed ID: 9503680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes and invariant alpha beta TCR expression of peripheral V alpha 14+ NK T cells.
    Masuda K; Makino Y; Cui J; Ito T; Tokuhisa T; Takahama Y; Koseki H; Tsuchida K; Koike T; Moriya H; Amano M; Taniguchi M
    J Immunol; 1997 Mar; 158(5):2076-82. PubMed ID: 9036951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development.
    Mycko MP; Ferrero I; Wilson A; Jiang W; Bianchi T; Trumpp A; MacDonald HR
    J Immunol; 2009 Apr; 182(8):4641-8. PubMed ID: 19342639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.
    Mieza MA; Itoh T; Cui JQ; Makino Y; Kawano T; Tsuchida K; Koike T; Shirai T; Yagita H; Matsuzawa A; Koseki H; Taniguchi M
    J Immunol; 1996 May; 156(10):4035-40. PubMed ID: 8621946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation.
    Prussin C; Foster B
    J Immunol; 1997 Dec; 159(12):5862-70. PubMed ID: 9550382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways.
    Ohteki T; Maki C; Koyasu S; Mak TW; Ohashi PS
    J Immunol; 1999 Apr; 162(7):3753-6. PubMed ID: 10201888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
    Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of NK1.1(+) invariant Valpha19 TCR(+) cells in the liver with potential to promptly respond to TCR stimulation.
    Shimamura M; Huang YY; Migishima R; Yokoyama M; Saitoh T; Yamamura T
    Immunol Lett; 2008 Nov; 121(1):38-44. PubMed ID: 18789972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
    Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
    Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity.
    Akbari O; Stock P; Meyer E; Kronenberg M; Sidobre S; Nakayama T; Taniguchi M; Grusby MJ; DeKruyff RH; Umetsu DT
    Nat Med; 2003 May; 9(5):582-8. PubMed ID: 12669034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundance of NKT cells in the salivary glands but absence thereof in the liver and thymus of aly/aly mice with Sjögren syndrome.
    Narita J; Kawamura T; Miyaji C; Watanabe H; Honda S; Koya T; Arakawa M; Abo T
    Cell Immunol; 1999 Mar; 192(2):149-58. PubMed ID: 10087183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells.
    Vallabhapurapu S; Powolny-Budnicka I; Riemann M; Schmid RM; Paxian S; Pfeffer K; Körner H; Weih F
    Eur J Immunol; 2008 Dec; 38(12):3508-19. PubMed ID: 19003818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
    Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.